Compare AU
Compare DRUG vs. WCMQ
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Global Healthcare ETF - Currency Hedged (DRUG) and the WCM Quality Global Growth Fund (Quoted Managed Fund) (WCMQ). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
DRUG | WCMQ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 63 | 1 |
Median incremental investment | $967.00 | $1,006.22 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,875.72 | $1,452.56 |
Average age group | 26 - 35 | > 35 |
Key Summary
DRUG | WCMQ | |
|---|---|---|
Strategy | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. | WCMQ.AX was created on 2018-09-03 by WCM. The fund's investment portfolio concentrates primarily on total market equity. To exceed the benchmark MSCI All Country World Index ex-Australia before taxes and fees over rolling three-year time periods, and to experience lower volatility than the benchmark. |
Top 3 holdings | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) | AppLovin Corp Ordinary Shares - Class A (6.22 %) GE Aerospace (4.72 %) Amazon.com Inc (4.70 %) |
Top 3 industries | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) | Information Technology (31.52 %) Other (17.50 %) Health Care (17.32 %) |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | United States (71.21 %) Canada (4.84 %) Denmark (4.43 %) |
Management fee | 0.57 % | 1.25 % |
Key Summary
DRUG | WCMQ | |
|---|---|---|
Issuer | BetaShares | WCM |
Tracking index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | |
Asset class | ETF | ETF |
Management fee | 0.57 % | 1.25 % |
Price | $8.12 | $10.84 |
Size | $191.120 million | $402.147 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 1.90 % | 3.86 % |
Market | ASX | ASX |
First listed date | 08/08/2016 | 03/09/2018 |
Purchase fee | $6.50 | $6.50 |
Community Stats
DRUG | WCMQ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 63 | 1 |
Median incremental investment | $967.00 | $1,006.22 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,875.72 | $1,452.56 |
Average age group | 26 - 35 | > 35 |
Pros and Cons
DRUG | WCMQ | |
|---|---|---|
Pros |
|
|
Cons |
|
|
DRUG | WCMQ |
|---|---|
Higher exposure to US market | Lower exposure to US market |
Lower management fee | Higher management fee |
Lower price growth | Higher price growth |
Lower distribution yield | Higher distribution yield |